Generation and metabolism of oxidized phospholipids which are active components in oxidized low density lipoprotein.

氧化磷脂的生成和代谢,氧化磷脂是氧化低密度脂蛋白的活性成分。

基本信息

  • 批准号:
    11672184
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Oxidized low density lipoprotein (OxLDL) is believed to be a cruicial factor for atherogenesis. Oxidized phosphatidylcholines (OxPC) formed in OxLDL should be key compounds for atherogenesis, since they are involved in recognition by macrophages and are capable of activating endothelial cells and other vascular cells. We investigated, by utilizing an anti-OxPC monoclonal antibody, DLH3, the metabolic fate of OxPC-apoB complex in foam cells and OxPC generation in various types of OxLDL preparations.Foam cells in human atherosclerotic lesions were simultaneously stained immunohistochemically with DLH3 and anti-apoB antibody, indicating accumulation of OxPC-apoB coomplex. Careful measurement of the amounts of OxPC-apoB coomplex present in J774 macrophages revealed that a part of OxLDL taken up by macrophages were accumulated in the cells. Partially degraded OxLDL (less than 100 kDa) were recovered in secondary lysosome fractions when intracellular organelles were fractionated on a sucrose … More density gradient. These observations provide a metabolic rationale why and how OxLDL-related antigens are accumulated in foam cells in atherosclerotic lesions.Recently, minimally modified LDL (MM-LDL), which is prepared by moderate oxidation contitions, is reported to be a good model for physiological OxLDL.We introduced a sensitve methos to measure free OxPCs containing aldehyde group by converting them to fluorescent derivertives after treatment with 1, 4-cyclohexanedione. MM-LDL was prepared by incubating LDL with FeSO4 at 4℃. Although modification status of whole particles for MM-LDL seemed to be very moderate judging by TBARS values and eleclromobility on agarose gel, the amounts of free and complex forms of OxPC generated in MM-LDL were rather higher than copper-treated OxLDL.It is certainly needed to test the biological properties of the MM-LDL preparations as the next step, but this observation might be a interesting clue to elucidate the contribution of OxPC formed in OxLDL for atherogenesis. Less
氧化的低密度脂蛋白(OXLDL)被认为是动脉粥样硬化的关键因素。在OXLDL中形成的氧化磷脂酰胆碱(OXPC)应该是动脉粥样硬化的关键化合物,因为它们参与了巨噬细胞的识别,并且能够激活内皮细胞和其他血管细胞。我们通过利用抗OXPC单克隆抗体DLH3(在各种类型的OXLDL制剂中的OXPC-APOB复合物和OXPC生成的代谢命运)进行了研究。人动脉粥样硬化病中的FOAM细胞与DLH3和Anti-apob Antbobs coimation coimations cocy cocy cocy cocy cocy cocy cocy cocy cocy cocy cocy cocompation cocompation cocompation cocompation cocy cocigation cocigation cocigation。仔细测量J774巨噬细胞中存在的OXPC-APOB COOMPLEX的量表明,在细胞中积累了巨噬细胞所吸收的一部分OXLDL。当细胞内细胞器在蔗糖上分级时,在次级溶酶体部分中回收了部分降解的OXLDL(小于100 kDa)……更多的密度梯度。 These observations provide a metabolic rationale why and how OxLDL-related antigens are accumulated in foam cells in atherosclerotic lesions.Recently, minimally modified LDL (MM-LDL), which is prepared by moderate oxidation regulations, is reported to be a good model for physical OxLDL.We introduced a sensitivity Methos to measure free OxPCs containing aldehyde group by converting them to用1个,4-环己二酮处理后的荧光衍生物。 MM-LDL是通过在4℃处与FESO4一起孵育LDL来制备的。尽管MM-LDL的整个颗粒的修改状态似乎是非常现代的,从TBARS值和对琼脂糖凝胶的Elecromisity来判断,但MM-LDL中产生的自由和复杂形式的OXPC的数量比铜处理的OXLDL更高,而不是铜处理的OXLDL。 OXPC在OXLDL中形成,用于动脉粥样硬化。较少的

项目成果

期刊论文数量(64)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Naba, I., Yoshikawa, H., Sakoda, S., Itabe, H., Suzuki, H., Kodama T., and Yanagihara, T.: "Successful generation of peripheral neuropathy with onion-bulb formation in the scavenger receptor classA knockout mouse treated with isoniazid."Neurosci.Lett.. 29
Naba, I.、Yoshikawa, H.、Sakoda, S.、Itabe, H.、Suzuki, H.、Kodama T. 和 Yanagihara, T.:“成功产生周围神经病变,并在清道夫受体中形成洋葱球
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mori,M., et al.: "Presence of phospholipid-neutral lipid complex structures in atherosclerotic lesions as detected by a novel monoclonal antibody."J.Biol.Chem.. 274. 24828-24837 (1999)
Mori,M., et al.:“通过新型单克隆抗体检测到动脉粥样硬化病变中存在磷脂-中性脂质复合物结构。”J.Biol.Chem.. 274. 24828-24837 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itabe,H., et al.: "Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages : Intracellular fate of oxidized low density lipoprotein."Biochim.Biophys.Acta. 1485. 233-245 (2000)
Itabe, H., et al.:“巨噬细胞中氧化磷脂酰胆碱-载脂蛋白 B 复合物的溶酶体积累:氧化低密度脂蛋白的细胞内命运。”Biochim.Biophys.Acta。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ehara,S., et al.: "Oxidized low density lipoprotein relates to plaque destabilization in human coronary atherosclerotic lesions."Circulation. (印刷中). (2001)
Ehara, S. 等人:“氧化低密度脂蛋白与人类冠状动脉粥样硬化病变中的斑块不稳定有关。”循环(2001 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kohno,H., et al.: "Simple and pactical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody."Clin.Biochem.. 33. 243-253 (
Kohno,H. 等人:“使用抗氧化磷脂酰胆碱单克隆抗体和抗人载脂蛋白 B 抗体对人氧化修饰低密度脂蛋白进行简单实用的夹心型酶免疫测定。”Clin.Biochem.. 33. 243-253(
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITABE Hiroyuki其他文献

ITABE Hiroyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITABE Hiroyuki', 18)}}的其他基金

Oxidatively modified high-density lipoprotein: its roles in vessel wall tissues and mechanism of its generation.
氧化修饰的高密度脂蛋白:其在血管壁组织中的作用及其生成机制。
  • 批准号:
    19K07051
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on process of generation and metabolism of oxidized LDL in vivo.
体内氧化型低密度脂蛋白生成及代谢过程的研究。
  • 批准号:
    15K07944
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sensitive measurement of oxidized phospholipids as markers of oxidative stress and diseases.
敏感测量氧化磷脂作为氧化应激和疾病的标志物。
  • 批准号:
    24590094
  • 财政年份:
    2012
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of plasma oxidized LDL in the early stages of atherogenesis
动脉粥样硬化早期血浆氧化低密度脂蛋白的产生
  • 批准号:
    21590073
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biological and pharmaceutical study on intracellular lipid droplets which are the key organelle to understand life style diseases.
细胞内脂滴的生物学和药学研究,细胞内脂滴是了解生活方式疾病的关键细胞器。
  • 批准号:
    19590076
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Separation and analysis of oxidized low-density lipoprotein in vivo using immunological technique.
使用免疫学技术分离和分析体内氧化低密度脂蛋白。
  • 批准号:
    16590065
  • 财政年份:
    2004
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modified structure and biological activities for oxidized LDL present in vivo searching for a better model for the physiological oxidized LDL
体内氧化低密度脂蛋白的修饰结构和生物活性寻找更好的生理氧化低密度脂蛋白模型
  • 批准号:
    13672303
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

补肺解毒方介导IFNγ-IRF1-Rsad2信号调控促进巨噬细胞泡沫化抑制MAB胞内存活的效应机制研究
  • 批准号:
    82374436
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
ZBP1介导线粒体自噬促进巨噬细胞泡沫化参与动脉粥样硬化发生的机制研究
  • 批准号:
    82300524
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于“PPARγ-CD36-VAV”途径研究针刺内关抑制巨噬细胞泡沫化调控动脉粥样硬化的作用机制
  • 批准号:
    82374602
  • 批准年份:
    2023
  • 资助金额:
    45 万元
  • 项目类别:
    面上项目
降脂颗粒抑制清道夫受体MSR1介导的巨噬细胞泡沫化改善非酒精性脂肪性肝炎的机制
  • 批准号:
    82274448
  • 批准年份:
    2022
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
活性多肽MFDP5抑制巨噬细胞泡沫化在动脉粥样硬化不稳定斑块中的作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目

相似海外基金

Mitochondrial-encoded immunity in restoring macrophage homeostasis under age-related metabolic stress
线粒体编码免疫在年龄相关代谢应激下恢复巨噬细胞稳态
  • 批准号:
    10680230
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Impact of Oxidative Modification on HDL Function
氧化修饰对 HDL 功能的影响
  • 批准号:
    9353659
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
Histone deacetylases and atherosclerosis
组蛋白脱乙酰酶和动脉粥样硬化
  • 批准号:
    7837085
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
Histone deacetylases and atherosclerosis
组蛋白脱乙酰酶和动脉粥样硬化
  • 批准号:
    7221251
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
Histone deacetylases and atherosclerosis
组蛋白脱乙酰酶和动脉粥样硬化
  • 批准号:
    7617915
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了